scholarly journals ‘I didn't even know boys could get the vaccine’: Parents' reasons for human papillomavirus (HPV) vaccination decision making for their sons

2015 ◽  
Vol 24 (10) ◽  
pp. 1316-1323 ◽  
Author(s):  
Samara Perez ◽  
Gilla K. Shapiro ◽  
Christopher A. Brown ◽  
Eve Dube ◽  
Gina Ogilvie ◽  
...  
2020 ◽  
Vol 16 (7) ◽  
pp. 1653-1658 ◽  
Author(s):  
Tomomi Egawa-Takata ◽  
Ruriko Nakae ◽  
Mariko Shindo ◽  
Ai Miyoshi ◽  
Tsuyoshi Takiuchi ◽  
...  

2021 ◽  
Author(s):  
Elisabeth R.B. Becker ◽  
Ross Shegog ◽  
Lara S. Savas ◽  
Erica L. Frost ◽  
C. Mary Healy ◽  
...  

BACKGROUND Human papillomavirus is a common and preventable sexually transmitted infection but vaccination rates in the U.S. among the target age group, 11-12 years old, are lower than national goals. Interventions that address the barriers and facilitators to vaccination are important in improving HPV vaccination rates. Online text-based focus groups are becoming a promising method that may be well-suited for conducting formative research to inform the design of digital behavior change intervention content and features that address HPV vaccination decision making. OBJECTIVE This study explores parental HPV vaccination decision-making processes using an online text-based focus group protocol in order to inform content and feature recommendations for an HPV prevention digital behavior change intervention. METHODS We conducted four online text-based synchronous focus groups via Skype with parents of 11-13-year-old patients within a large urban U.S. pediatric clinic network. RESULTS The 22 parents were majority female, white non-Hispanic, had a graduate or professional degree and had private health insurance for their children. Fifty-six percent of the parents’ 11-13-year-old children had initiated HPV vaccination. Most parents had experience using Skype (82%). Parents requested a text-only chat format (47%) over an audio-visual call format (6%) for their focus group. The three main themes from the qualitative data were (1) HPV vaccination misinformation and confusion; (2) HPV beliefs and attitudes; and (3) facilitators to vaccination. Eleven intervention content and feature recommendations emerged from the themes including: address HPV knowledge barriers using trusted sources; design for a family audience; focus on the framing of messages; report reputable HPV research in a digestible format; and expand the clinic visit experience. CONCLUSIONS Synchronous text-based focus groups are feasible for conducting formative research on HPV vaccination decision making. Among well-educated and well-resourced parents, there is misinformation about HPV and knowledge barriers that influence HPV attitudes and beliefs. Parents want to conduct their own HPV research as well as receive relevant HPV vaccination advice from their child’s pediatrician. In addition, parents want an enhanced clinic visit experience which lets them access and connect to tailored information before and after clinic visits. The results gathered provide guidance for content and features that may inform a more responsive digital behavior change intervention to address HPV vaccination decision making among parents.


2021 ◽  
Author(s):  
Elisabeth R.B. Becker ◽  
Ross Shegog ◽  
Lara S. Savas ◽  
Erica L. Frost ◽  
Sharon P. Coan ◽  
...  

BACKGROUND HPV-attributed cancers are preventable, yet HPV vaccination rates severely lag other adolescent vaccinations. HPVcancerFree is an mHealth intervention developed to influence parental HPV vaccination decision making by raising awareness of HPV, reducing HPV vaccination barriers and enabling HPV vaccination scheduling and reminders through a smartphone. Evaluating the feasibility and user experience of mHealth interventions are vital components in assessing their quality and success. OBJECTIVE We aimed to evaluate the feasibility of HPVcancerFree using mixed methods data collected from log files, survey measures and qualitative feedback METHODS Study data was evaluated from parents in a large U.S. pediatric clinic network using HPVcancerFree in the intervention arm of a group randomized controlled trial. Log data captured HPVcancerFree retention and use. Post intervention rating scales and items, including the uMARS survey (reflecting engagement, functionality, aesthetics and information), assessed HPVcancerFree utility, usefulness, understandability, appeal, credibility, perceived impact and overall quality. Open-ended responses assessed patient recommendations for HPVcancerFree enhancement. RESULTS The 98 parent participants were mainly female (96%), 41±5.67 years of age, college educated (56%), white, non-Hispanic (56%) and had private health insurance for their children (77%). Parents used HPVcancerFree 197 times with average visit duration approximating 3.5 minutes. The uMARS app quality score was positively skewed (4.2/5). Mean ratings were highest for information (4.46±0.53) and lowest on engagement (3.74±0.69). Forty-seven percent of parents rated HPVcancerFree as helpful in HPV vaccination decision making and 17% attributed HPV vaccine initiation to HPVcancerFree. Parents reported that HPVcancerFree increased their awareness (89%), knowledge (89%) and HPV vaccination intentions (68%). Most parents rated the four HPVcancerFree components as useful (74-94%). Parents agreed that HPVcancerFree was clear (91%), accurate (91%), and more helpful than other HPV vaccine information they had received (94%), and that they would recommend it to others (85%). Parents suggested increasing awareness about the app, incorporating a tailored reminder system and creating opportunities to engage with adolescents about HPV and sexual health as enhancements for future iterations. CONCLUSIONS HPVcancerFree is a feasible mHealth intervention to support regular pediatric clinic HPV vaccine education. HPVCF was well received by parents. Future research is indicated to determine its efficacy to persuade parents to vaccinate and best promotional strategies to motivate parents to use HPVcancerFree.


Vaccine ◽  
2017 ◽  
Vol 35 (36) ◽  
pp. 4713-4721 ◽  
Author(s):  
Samara Perez ◽  
Ovidiu Tatar ◽  
Vladimir Gilca ◽  
Gilla K. Shapiro ◽  
Gina Ogilvie ◽  
...  

2017 ◽  
Vol 60 (2) ◽  
pp. S8-S9
Author(s):  
Joan R. Cates ◽  
Bernard Fuemmeler ◽  
Sandra J. Diehl ◽  
Laurie Stockton ◽  
Jeannette Porter ◽  
...  

2019 ◽  
Author(s):  
Serena Xiong ◽  
Maiyia Y. Kasouaher ◽  
Bai Vue ◽  
Kathleen A. Culhane-Pera ◽  
Shannon L. Pergament ◽  
...  

Abstract Background: Human papillomavirus (HPV) vaccination rates in Asian-American/Pacific- Islander (AAPI) populations are substantially lower than majority Americans. No studies have assessed HPV vaccine rates in the Hmong population, an AAPI group with increased risks of cervical and nasopharyngeal cancer. In 2015, the HPV vaccinations rates for Hmong girls and boys ages 9-17 at a Minnesota community health center (CHC) were 32% and 20%, lower than national 2017 HPV rates of 47% and 53%. This qualitative community-based participatory action research study identified multilevel barriers, facilitators, and decision-making processes about HPV vaccinations among Hmong adolescents and parents. Methods: Bilingual community researchers recruited Hmong adolescents and their parents from a community health center, conducted eight focus groups with 12 adolescents and 13 parents. Participants also completed demographic and HPV knowledge surveys. The research team analyzed transcripts using participatory thematic analysis and identified themes using a multilevel socioecological model combined with an assets lens. Results: Both survey and focus group results showed that Hmong adolescents and parents had low levels of HPV and HPV vaccine awareness. At the individual-level, both adolescents and parents reported concerns about side-effects and cost as reasons for not getting any type of vaccination, however they also expressed a strong desire to learn about HPV and the HPV vaccine. Community-level barriers identified included community narratives around traumatic experiences with vaccines, and facilitators included family and community connections and communications. At the institutional-level, barriers included structural constraints in health care settings, while facilitators included ease of obtaining vaccines at school-based clinics and provider authoritative decision-making. Finally, there was a range of decision-making processes between parents and adolescents and between parents and providers. Conclusion: A linguistically and culturally-specific HPV educational program for Hmong adolescents and parents could address barriers and build on facilitators and assets to promote HPV vaccine uptake. These findings have informed the development of an eHealth application to increase HPV vaccinations in Hmong adolescents. Future research will test the feasibility, acceptability, and efficacy of culturally-tailored, multilevel HPV vaccination interventions that may provide evidence about the efficacy of culturally-appropriate education in comprehensive vaccine strategies.


10.2196/30340 ◽  
2021 ◽  
Author(s):  
Elisabeth R.B. Becker ◽  
Ross Shegog ◽  
Lara S. Savas ◽  
Erica L. Frost ◽  
Sharon P. Coan ◽  
...  

2008 ◽  
Vol 13 (33) ◽  
Author(s):  
L A King ◽  
D Lévy-Bruhl ◽  
D O'Flanagan ◽  
S Bacci ◽  
P L Lopalco ◽  
...  

The European Union Member States are simultaneously considering introducing HPV vaccination into their national immunisation schedules. The Vaccine European New Integrated Collaboration Effort (VENICE) project aims to develop a collaborative European vaccination network. A survey was undertaken to describe the decision status and the decision-making process regarding the potential introduction of human papillomavirus (HPV) vaccination into their national immunisation schedules. A web-based questionnaire was developed and completed online in 2007 by 28 countries participating in VENICE. As of 31 October 2007, five countries had decided to introduce HPV vaccination into the national immunisation schedule, while another seven had started the decision-making process with a recommendation favouring introduction. Varying target populations were selected by the five countries which had introduced the vaccination. Half of the surveyed countries had undertaken at least one ad hoc study to support the decision-making process. According to an update of the decision-status from January 2008, the number of countries which had made a decision or recommendation changed to 10 and 5 respectively. This survey demonstrates the rapidly evolving nature of HPV vaccine introduction in Europe and the existence of expertise and experience among EU Member States. The VENICE network is capable of following this process and supporting countries in making vaccine introduction decisions. A VENICE collaborative web-space is being developed as a European resource for the decision-making process for vaccine introduction.


Sign in / Sign up

Export Citation Format

Share Document